Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer

This publication has 25 references indexed in Scilit:

• Genome‐wide profiling of oral squamous cell carcinoma
  The Journal of Pathology, 2004
• Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth
  Oncogene, 2004
• Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer
  Thrombosis and Haemostasis, 2004
• The PAI-I gene 4G/5G Polymorphism and Deep Vein Thrombosis in Patients with Inherited Thrombophilia
  Clinical and Applied Thrombosis/hemostasis, 2003
• Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis
  Cancer Letters, 2003
• Molecular pathogenesis of oral squamous carcinoma
  Molecular Pathology, 2000
• Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells
  Oral Oncology, 1999
• The urokinase-type plasminogen activator system in cancer metastasis: A review
  International Journal of Cancer, 1997
• A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSIS
  Thrombosis Research, 1996
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
  Proceedings of the National Academy of Sciences, 1995